Inhaled corticosteroids, blood eosinophils, and FEV(1) decline in patients with COPD in a large UK primary health care setting

Background: Inhaled corticosteroid (ICS)-containing medications slow rate of decline of FEV(1). Blood eosinophil (EOS) levels are associated with the degree of exacerbation reduction with ICS. Purpose: We investigated whether FEV(1) decline differs between patients with and without ICS, stratified b...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Chron Obstruct Pulmon Dis
Autors principals: Whittaker, Hannah R, Müllerova, Hana, Jarvis, Deborah, Barnes, Neil C, Jones, Paul W, Compton, Chris H, Kiddle, Steven J, Quint, Jennifer K
Format: Artigo
Idioma:Inglês
Publicat: Dove 2019
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6536812/
https://ncbi.nlm.nih.gov/pubmed/31213788
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S200919
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars